Telomerase in the early detection of cancer

Research output: Contribution to journalArticle

170 Citations (Scopus)

Abstract

Although there is justifiable optimism regarding telomerase activity and early detection of cancer, it is important to point out that there is much that remains to be understood and additional validation studies will be required before knowledge of telomerase activity will be useful in decisions regarding patient management. A key question is whether we will be able to distinguish those cancers that are going to progress from those cancers that are not by detecting telomerase activity. Molecular staging using markers such as telomerase activity in combination with other molecular markers may be particularly useful in this regard. Basic scientists and clinicians must-work together if this strategy is to mature. Telomerase inhibitors in the treatment of cancer are awaited with great anticipation.

Original languageEnglish (US)
Pages (from-to)106-109
Number of pages4
JournalJournal of Clinical Pathology
Volume50
Issue number2
StatePublished - 1997

Fingerprint

Telomerase
Early Detection of Cancer
Neoplasms
Validation Studies

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Telomerase in the early detection of cancer. / Shay, J. W.; Gazdar, A. F.

In: Journal of Clinical Pathology, Vol. 50, No. 2, 1997, p. 106-109.

Research output: Contribution to journalArticle

@article{a01cc63092ea487f9778baa530afd4c3,
title = "Telomerase in the early detection of cancer",
abstract = "Although there is justifiable optimism regarding telomerase activity and early detection of cancer, it is important to point out that there is much that remains to be understood and additional validation studies will be required before knowledge of telomerase activity will be useful in decisions regarding patient management. A key question is whether we will be able to distinguish those cancers that are going to progress from those cancers that are not by detecting telomerase activity. Molecular staging using markers such as telomerase activity in combination with other molecular markers may be particularly useful in this regard. Basic scientists and clinicians must-work together if this strategy is to mature. Telomerase inhibitors in the treatment of cancer are awaited with great anticipation.",
author = "Shay, {J. W.} and Gazdar, {A. F.}",
year = "1997",
language = "English (US)",
volume = "50",
pages = "106--109",
journal = "Journal of Clinical Pathology - Clinical Molecular Pathology",
issn = "0021-9746",
publisher = "BMJ Publishing Group",
number = "2",

}

TY - JOUR

T1 - Telomerase in the early detection of cancer

AU - Shay, J. W.

AU - Gazdar, A. F.

PY - 1997

Y1 - 1997

N2 - Although there is justifiable optimism regarding telomerase activity and early detection of cancer, it is important to point out that there is much that remains to be understood and additional validation studies will be required before knowledge of telomerase activity will be useful in decisions regarding patient management. A key question is whether we will be able to distinguish those cancers that are going to progress from those cancers that are not by detecting telomerase activity. Molecular staging using markers such as telomerase activity in combination with other molecular markers may be particularly useful in this regard. Basic scientists and clinicians must-work together if this strategy is to mature. Telomerase inhibitors in the treatment of cancer are awaited with great anticipation.

AB - Although there is justifiable optimism regarding telomerase activity and early detection of cancer, it is important to point out that there is much that remains to be understood and additional validation studies will be required before knowledge of telomerase activity will be useful in decisions regarding patient management. A key question is whether we will be able to distinguish those cancers that are going to progress from those cancers that are not by detecting telomerase activity. Molecular staging using markers such as telomerase activity in combination with other molecular markers may be particularly useful in this regard. Basic scientists and clinicians must-work together if this strategy is to mature. Telomerase inhibitors in the treatment of cancer are awaited with great anticipation.

UR - http://www.scopus.com/inward/record.url?scp=0031043998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031043998&partnerID=8YFLogxK

M3 - Article

VL - 50

SP - 106

EP - 109

JO - Journal of Clinical Pathology - Clinical Molecular Pathology

JF - Journal of Clinical Pathology - Clinical Molecular Pathology

SN - 0021-9746

IS - 2

ER -